23. Hoffman K. E., Yanelli K., Bridges K. R. Ascorbic acid and iron metabolism: alterations in lysosomal function. The American Journal of Clinical Nutrition, 1991, vol. 54, no. 5. pp. 1188S-1192S. doi: 10.1093/ajcn/54.6.1188s.
24. Islam S., Chisti M. J., Ahmed М., Anwar N., Lehmann C. Bacterial resistance in pneumonia in developing countries-a role for iron chelation. Tropical Medicine and Infectious Disease, 2019, vol. 4, no. 2. p. 59. doi: 10.3390/tropicalmed4020059.
25. Kim S. J., Park R. Y, Kang S. M., Choi M. H., Kim C. M., Shin S. H. Pseudomonas aeruginosa alkaline protease can facilitate siderophore-mediated iron-uptake via the proteolytic cleavage of transferrins. Biological and Pharmaceutical Bulletin, 2006, vol. 29, no. 11, pp. 2295-2300. doi: 10.1248/bpb.29.2295.
26. Lane D. J., Bae D.H., Merlot A. M., Sahni S., Richardson D. R. Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation. Nutrients, 2015, vol. 7, no. 4 pp. 2274-2296.
27. Mossialos D., Amoutzias G. D. Role of siderophores in cystic fibrosis pathogenesis: foes or friends? International Journal of Medical Microbiology, 2009, vol. 299, no. 2 pp. 87-98. doi:10.1016/j.ijmm.2008.06.008.
28. Nairz M., Haschka D., Demetz E., Weiss G Iron at the interface of immunity and infection. Frontiers in Pharmacology, 2014, no. 5, p. 152. doi: 10.3389/fphar.2014.00152.
29. Nairz M., Schroll A., Sonnweber T., Weiss G The struggle for iron a metal at the host-pathogen interface. Cellular Microbiology, 2010, vol. 12, no. 12 pp. 1691-1702. doi:10.1111/j.1462-5822.2010.01529.x.
30. Oda K., Kikuchi E., Kuroda E., Yamada C., Okuno C., Urata N., Kishimoto N., Kubo A., Ishii N., Nishizaki Y. Uric acid, ferritin and y-glutamyltransferase can be informative in prediction of the oxidative stress. Journal of Clinical Biochemistry and Nutrition, 2019, vol. 64, no. 2, pp. 124-128. doi:10.3164/jcbn.18-23.
31. Pond M. N., Morton A. M., Conway S. P. Conway. Functional iron deficiency in adults with cystic fibrosis. Respiratory Medicine, 1996, vol. 90, no. 7, pp. 409-413.
32. Reid D. W., Withers N. J., Francis L., Wilson J. W., Kotsimbos T. C. Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection, 2002, vol. 121, no. 1 pp. 48-54.
33. Semler D. D., Goudie A. D., Finlay W. H., Dennis J. J. Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections. Antimicrobial agents and chemotherapy, 2014, vol. 58, no. 7, pp. 4005-4013. doi:10.1128/AAC.02388-13.
34. Stites S. W., Walters B., O'Brien-Ladner A. R., Bailey K., Wesselius L. J. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest., 1998, vol. 114, no. 3 pp. 814-819.
35. Thomas, M. S. Iron acquisition mechanisms of the Burkholderia cepacia complex. Biometals, 2007, vol. 20, no. 3-4, pp. 431-452. doi:10.1007/s10534-006-9065-4.
36. Toth I., Rogers J. T., McPhee J. A., Elliott S. M., Abramson S. L., Bridges K. R. Ascorbic acid enhances iron-induced ferritin translation in human leukemia and hepatoma cells. Journal of Biological Chemistry, 1995, vol. 270, no. 6, pp. 2846-2852. doi: 10.1074/jbc.270.6.2846.
37. Ward D. M., Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochimica et Biophysica Acta, 2012, vol. 1823, no. 9, pp. 1426-1433.
38. Weinberg, E. D. Iron availability and infection. Biochimica et Biophysica Acta, 2009. vol. 1790, no. 7, pp. 600-605. doi: 10.1016/j.bbagen.2008.07.002.
39. Wiens J. R., Vasil A. I., Schurr M. J., Vasil M. L. Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa. MBio, 2014, vol. 5, no. 1, рр. e01010-e01013. doi: 10.1128/mBio.01010-13.
40. Wilderman P. J., Vasil A. I., Johnson Z., Wilson M. J., Cunliffe H. E., Lamont I. L., Vasil M. L. Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infection and Immunity, 2001, vol. 69, no. 9, pp. 5385-5394. doi: 10.1128/IAI.69.9.5385-5394.2001.
41. Wilschanski, M. Novel Therapeutic Approaches for Cystic Fibrosis. Discovery medicine, 2013, vol. 15, no. 81, pp. 127-133.
42. Wolz C., Hohloch K., Ocaktan A., Poole K., Evans R. W., Rochel N., Albrecht-Gary A. M., Abdallah M. A., Dцring G. Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa. Infection and Immunity, 1994, vol. 62, no. 9, pp. 4021-4027.